Lantheus Holdings Stock News

BEDFORD, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fig

Recently, Zacks.com users have been paying close attention to Lantheus Holdings (LNTH). This makes it worthwhile to examine what the stock has in store.

Risk and reward have an inverse relationship. It's one of the guiding principles of investing in stocks and any other asset.

Lantheus Holdings (LNTH) closed at $69.21 in the latest trading session, marking a -1.8% move from the prior day.

Zacks.com users have recently been watching Lantheus Holdings (LNTH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Right now, investors would be wise to consider the small-cap stocks that populate the Russell 2000 Index. The Russell 2000 Index represents the smallest firms by market capitalization.

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

If you're putting together a list of overlooked AI stocks, I wouldn't try to sneak Nvidia (NASDAQ: NVDA ) on it. Even investor neophytes know about CEO Jensen Huang's obsession with artificial intelli

Artificial intelligence is still all the rage with investors, but the hype has pushed many stocks to unsustainable heights. Now that the irrational frenzy is cooling off, some compelling opportunities

Lantheus Holdings (LNTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in

Recently, Zacks.com users have been paying close attention to Lantheus Holdings (LNTH). This makes it worthwhile to examine what the stock has in store.

Investors need to pay close attention to Lantheus Holdings (LNTH) stock based on the movements in the options market lately.

Radiopharmacy is expected to experience exponential growth over the next decade. Radiopharmaceutical-based therapies offer more targeted and specific approaches for cancer treatment and medical imagin

Zacks.com users have recently been watching Lantheus Holdings (LNTH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.